TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16343112

Group type: EXPERIMENTAL
Intervention: Er : YAG laser at 16 Hz and 200 mJ input (120 mJ output)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Er : YAG laser at 16 Hz and 400 mJ input (240 mJ output)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nd : YAG laser at 15 Hz and 1 W input (0.4 W output)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nd : YAG laser at 15 Hz and 2 W input (0.8 W output)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 17% EDTAC
Number of subjects: 90
Study: 12505116

Group type: EXPERIMENTAL
Intervention: House officer-attending physician conference room discussion plus attending physician-patient interaction
Number of subjects: 393

Group type: COMPARATOR
Intervention: Exclusive house officer-attending physician conference room discussion
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Exclusive house officer-attending physician discussion in the examining room with the patient present
Number of subjects: 393
Study: 9649660

Group type: EXPERIMENTAL
Intervention: Lymecycline (300 mg/day for 2 weeks, then 150 mg/day for 10 weeks)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Minocycline (100 mg/day for 2 weeks then 100 mg every other day for 10 weeks)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Lymecycline
Number of subjects: 144

Group type: COMPARATOR
Intervention: Minocycline
Number of subjects: 144
Study: 7545768

Group type: EXPERIMENTAL
Intervention: Device implantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electrophysiologic studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation
Number of subjects: 0
Study: 30208761

Group type: EXPERIMENTAL
Intervention: Burn 2 Learn intervention (high-intensity interval training), 3 sessions per week for 14 weeks.
Number of subjects: 68

Group type: COMPARATOR
Intervention: Wait-list control group (no intervention).
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Burn 2 Learn intervention (high-intensity interval training).
Number of subjects: 68
Study: 28622405

Group type: EXPERIMENTAL
Intervention: Arte con Salud intervention
Number of subjects: 86

Group type: COMPARATOR
Intervention: Community-academic collaboration
Number of subjects: 86
Study: 22535548

Group type: EXPERIMENTAL
Intervention: Group Visits (GV)
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Usual Care (Control)
Number of subjects: 1024
Study: 24063843

Group type: EXPERIMENTAL
Intervention: Intracoronary abciximab
Number of subjects: 407

Group type: COMPARATOR
Intervention: No abciximab
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Manual aspiration
Number of subjects: 407

Group type: COMPARATOR
Intervention: No aspiration
Number of subjects: 407
Study: 21616977

Group type: EXPERIMENTAL
Intervention: MDMA (75 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 19144729

Group type: EXPERIMENTAL
Intervention: Combined testosterone (40 mg daily for women, 80 mg twice daily for men) and nutritional supplement (475 kcal/d)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Combined testosterone and nutritional supplement
Number of subjects: 49

Group type: COMPARATOR
Intervention: Testosterone treatment
Number of subjects: 49

Group type: COMPARATOR
Intervention: Nutritional supplement
Number of subjects: 49

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 49
Study: 17545208

Group type: EXPERIMENTAL
Intervention: Computer-based system for assessing tremor using a shape-tracing task on a graphic tablet.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (10 healthy individuals) performing the same shape-tracing task.
Number of subjects: 22
Study: 14970111

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg TID
Number of subjects: 38
Study: 11477352

Group type: EXPERIMENTAL
Intervention: Inactivated hepatitis A vaccine (2 doses, 6 months apart)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Unvaccinated control group (n=45)
Number of subjects: 37
Study: 9570178

Group type: EXPERIMENTAL
Intervention: Fludrocortisone acetate (0.1-0.2 mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 7520643

Group type: EXPERIMENTAL
Intervention: Isoprinosine
Number of subjects: 832

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 832
Study: 3052462

Group type: EXPERIMENTAL
Intervention: Theophylline + Ambroxol (TA) - 700 mg theophylline, 60 mg ambroxol/d for 5 days
Number of subjects: 19

Group type: COMPARATOR
Intervention: Ambroxol (A) - 60 mg ambroxol/d for 5 days
Number of subjects: 19
Study: 4609556

Group type: EXPERIMENTAL
Intervention: 2% hexachlorophane
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.75% Irgasan DP 300 bar soap
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unmedicated bar soap
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine detergent solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3% hexachlorophane detergent cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2% Irgasan DP 300 detergent solution
Number of subjects: 0
Study: 28455158

Group type: EXPERIMENTAL
Intervention: sedated EGD (sEGD)
Number of subjects: 209

Group type: COMPARATOR
Intervention: hospital unsedated transnasal endoscopy (huTNE)
Number of subjects: 209

Group type: COMPARATOR
Intervention: mobile unsedated transnasal endoscopy (muTNE)
Number of subjects: 209

Group type: COMPARATOR
Intervention: unsedated transnasal endoscopy (uTNE)
Number of subjects: 209
Study: 28489032

Group type: COMPARATOR
Intervention: Serum 25(OH)D concentrations in critical HFMD group (20.0 ± 8.4 ng/mL)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: 25(OH)D deficiency group in critical and severe HFMD
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Death group in critical and severe HFMD
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D concentration
Number of subjects: 138
Study: 26189433

Group type: EXPERIMENTAL
Intervention: Lonafarnib 100 mg twice daily for 28 days (group 1)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Lonafarnib 200 mg twice daily for 28 days (group 2)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Lonafarnib (both doses)
Number of subjects: 14
Study: 23245622

Group type: EXPERIMENTAL
Intervention: Echocardiography screening in group 1 (aged 5-15 years)
Number of subjects: 2004

Group type: EXPERIMENTAL
Intervention: Echocardiography screening in group 2 (aged 16-18 years)
Number of subjects: 2004
Study: 21389753

Group type: EXPERIMENTAL
Intervention: Combined therapy (COMB) - 8 weekly body-mind-spirit group psychotherapy sessions added to pharmacotherapy
Number of subjects: 63

Group type: COMPARATOR
Intervention: Monotherapy (MT) - pharmacotherapy only
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Combined therapy (COMB)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Monotherapy (MT)
Number of subjects: 63
Study: 18492847

Group type: EXPERIMENTAL
Intervention: Infant milk formula with 6 g/L short-chain galacto- and long-chain fructo-oligosaccharides (scGOS/lcFOS)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control group (without scGOS/lcFOS)
Number of subjects: 215
Study: 16872565

Group type: EXPERIMENTAL
Intervention: 50 mg/kg GHB (Xyrem) alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 50 mg/kg GHB (Xyrem) combined with 0.6 g/kg ethanol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 16
Study: 14600188

Group type: EXPERIMENTAL
Intervention: ETC-216 (recombinant ApoA-I Milano/phospholipid complexes) at 15 mg/kg or 45 mg/kg
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Combined treatment groups (ETC-216)
Number of subjects: 123
Study: 11029136

Group type: EXPERIMENTAL
Intervention: Peer feedback program (PFP)
Number of subjects: 91

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 91
Study: 8609686

Group type: EXPERIMENTAL
Intervention: PRP-T vaccine given to mothers during the third trimester and infants at 2, 3, and 4 months of age
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: PRP-T vaccine given to mothers and inactivated poliovirus vaccine to infants
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Meningococcal A and C vaccine given to mothers and PRP-T to infants
Number of subjects: 451

Group type: COMPARATOR
Intervention: Unvaccinated mothers
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Infants of vaccinated mothers
Number of subjects: 451

Group type: COMPARATOR
Intervention: Infants of unvaccinated mothers
Number of subjects: 451
Study: 1358134

Group type: EXPERIMENTAL
Intervention: esmolol 1.5 mg/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 20
Study: 3883685

Group type: EXPERIMENTAL
Intervention: Flupentixol (0.5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relaxation with specific training for the pain site
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unspecific relaxation control procedure
Number of subjects: 0
Study: 30738680

Group type: EXPERIMENTAL
Intervention: Oral vaccination
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Intranasal vaccination
Number of subjects: 399

Group type: COMPARATOR
Intervention: Control group (unvaccinated)
Number of subjects: 399
Study: 30092413

Group type: EXPERIMENTAL
Intervention: Expedited transfer to cardiac arrest center (CAC) with 24/7 access to interventional cardiology facilities, cooling, and goal-directed therapies
Number of subjects: 860

Group type: COMPARATOR
Intervention: Standard of care (delivery to the nearest emergency department)
Number of subjects: 860
Study: 27074066

Group type: EXPERIMENTAL
Intervention: Decompression surgery plus fusion surgery (fusion group)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Decompression surgery alone (decompression‐alone group)
Number of subjects: 247
Study: 25265492

Group type: EXPERIMENTAL
Intervention: Dabrafenib (150 mg orally twice daily) and trametinib (2 mg orally once daily)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Dabrafenib and placebo
Number of subjects: 423
Study: 22356216

Group type: COMPARATOR
Intervention: Control (lactated Ringer's)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Theophylline (4 mm)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: L-NAME (10 mm)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Theophylline + L-NAME (4 mm + 10 mm)
Number of subjects: 8
Study: 21161118

Group type: EXPERIMENTAL
Intervention: Implant anchorage assisted self-ligating appliance (G1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Self-ligating appliance (G2)
Number of subjects: 20
Study: 18057680

Group type: EXPERIMENTAL
Intervention: Clofibate (100 mg/Kg) plus phototherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Phototherapy
Number of subjects: 60
Study: 15138649

Group type: EXPERIMENTAL
Intervention: Group A: Sound or music distraction using white noise generators or hearing aids
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group B: Imagination distraction using light and warmth stimuli
Number of subjects: 40
Study: 11441371

Group type: EXPERIMENTAL
Intervention: High-velocity leg exercises 3 times weekly with weekly increases in resistance combined with 45 minutes of moderate, nonresistance exercise weekly.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Moderate intensity exercise 30 minutes daily, 6 days weekly (self-paced walking program).
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: High-velocity leg exercises 3 times weekly.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: High-velocity leg exercises 3 times weekly and moderate intensity exercise.
Number of subjects: 43
Study: 9604603

Group type: EXPERIMENTAL
Intervention: Serum magnesium levels in malnourished children
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Serum magnesium levels in marasmic children
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Serum magnesium levels correlation
Number of subjects: 46
Study: 8040762

Group type: EXPERIMENTAL
Intervention: Physical activity in prepubertal children
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sexual maturation (Tanner stage)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Increases in height and weight
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Calf muscle area
Number of subjects: 90
Study: 2471213

Group type: EXPERIMENTAL
Intervention: 7.5% NaCl/6% Dextran 70 (HSD) solution
Number of subjects: 32

Group type: COMPARATOR
Intervention: Lactated Ringers (LR) solution
Number of subjects: 32
Study: 31894731

Group type: EXPERIMENTAL
Intervention: Specialist Palliative Care Needs Rounds
Number of subjects: 1700
Study: 30741988

Group type: EXPERIMENTAL
Intervention: Shortened version of the EORTC QLQ-BR23 scales
Number of subjects: 10794

Group type: COMPARATOR
Intervention: Original EORTC QLQ-BR23 scales
Number of subjects: 10794
Study: 30113269

Group type: EXPERIMENTAL
Intervention: Catheter-based endovascular revascularisations
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Open-surgical endarterectomy
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Bypass surgery
Number of subjects: 10000
Study: 27177451

Group type: EXPERIMENTAL
Intervention: Incobotulinum toxin A (Xeomin(®))
Number of subjects: 35

Group type: COMPARATOR
Intervention: Onabotulinum toxin A (Botox(®))
Number of subjects: 35
Study: 24829204

Group type: EXPERIMENTAL
Intervention: KLF1 mutations in β-thalassemia patients
Number of subjects: 5029

Group type: EXPERIMENTAL
Intervention: KLF1 mutations
Number of subjects: 5029

Group type: EXPERIMENTAL
Intervention: KLF1 mutations in β-thalassemia intermedia patients
Number of subjects: 5029
Study: 22336631

Group type: EXPERIMENTAL
Intervention: Caffeine (5 to 7 mg/kg)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Caffeine (5 to 7 mg/kg) in participants heterozygous at rs5751876 and rs2298383
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Caffeine (5 to 7 mg/kg) in participants minor homozygous at rs5751876 and rs2298383
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Caffeine (5 to 7 mg/kg) in participants minor homozygous at rs2472304
Number of subjects: 78
Study: 20078830

Group type: EXPERIMENTAL
Intervention: Calcium supplements (1500 mg calcium/day in 3 divided doses)
Number of subjects: 510

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 510
Study: 17610879

Group type: EXPERIMENTAL
Intervention: 600 mug oral misoprostol
Number of subjects: 270

Group type: COMPARATOR
Intervention: Manual vacuum aspiration (MVA)
Number of subjects: 270
Study: 16291468

Group type: EXPERIMENTAL
Intervention: Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument
Number of subjects: 104
Study: 11991447

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D3 fixed combination (n = 199)
Number of subjects: 583

Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D3 separate combination (n = 190)
Number of subjects: 583

Group type: COMPARATOR
Intervention: Placebo group (n = 194)
Number of subjects: 583

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D3 treatment (both fixed and separate combinations)
Number of subjects: 583

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 583

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D3 treatment
Number of subjects: 583
Study: 10466286

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 0
Study: 7590047

Group type: EXPERIMENTAL
Intervention: Endoscopic injection therapy with absolute ethanol
Number of subjects: 62

Group type: COMPARATOR
Intervention: 0.1% epinephrine and thrombin spray (control group)
Number of subjects: 62
Study: 2291869

Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg ER once daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 6106039

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 55
Study: 30342326

Group type: EXPERIMENTAL
Intervention: Nurse-initiated protocols for fever, hyperglycaemia, and swallowing management in intervention hospitals.
Number of subjects: 1126

Group type: EXPERIMENTAL
Intervention: Venous blood glucose taken on admission to hospital or within 2 hours of stroke unit admission.
Number of subjects: 1126

Group type: EXPERIMENTAL
Intervention: Finger-prick blood glucose measured within 72 hours of stroke unit admission.
Number of subjects: 1126

Group type: EXPERIMENTAL
Intervention: Swallowing screening or assessment performed within 24 hours of stroke unit admission.
Number of subjects: 1126
Study: 29173323

Group type: EXPERIMENTAL
Intervention: Breastfeeding initiation within the first hour of birth
Number of subjects: 4203

Group type: COMPARATOR
Intervention: Delayed breastfeeding initiation (>1 hour after birth)
Number of subjects: 4203

Group type: COMPARATOR
Intervention: Delayed breastfeeding initiation
Number of subjects: 4203
Study: 25711158

Group type: EXPERIMENTAL
Intervention: Formulation 1 (F1) - microencapsulated fish oil powder
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Formulation 2 (F2) - microencapsulated fish oil powder
Number of subjects: 47

Group type: COMPARATOR
Intervention: Fish Oil Gel Capsules (FOGC)
Number of subjects: 47
Study: 24121917

Group type: EXPERIMENTAL
Intervention: Cleaning by plasma of Argon (G3)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Laboratory customization and cleaning by steam (G2)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No treatment (G1)
Number of subjects: 18
Study: 22064267

Group type: EXPERIMENTAL
Intervention: Kinrix™ + MMR + Varicella (V)
Number of subjects: 478

Group type: COMPARATOR
Intervention: Kinrix™ + MMR
Number of subjects: 478
Study: 19191793

Group type: EXPERIMENTAL
Intervention: PEG hydrogel membrane (test group, 19 patients)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Collagen membrane (control group, 18 patients)
Number of subjects: 37
Study: 17196327

Group type: EXPERIMENTAL
Intervention: Allogeneic transplant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel therapeutic approaches
Number of subjects: 0
Study: 15663459

Group type: EXPERIMENTAL
Intervention: High ventilation rate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High temperature (> 25.4 degrees C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long shifts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Understaffing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ventilation rates exceeding ASHRAE Standard 62
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High temperature
Number of subjects: 0
Study: 11943530

Group type: COMPARATOR
Intervention: Propofol (Group P; n = 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fentanyl 2 microg/kg IV followed by propofol (Group PF; n = 20)
Number of subjects: 40
Study: 9616533

Group type: EXPERIMENTAL
Intervention: Salbutamol inhaled via Turbuhaler
Number of subjects: 12

Group type: COMPARATOR
Intervention: Salbutamol inhaled via pMDI
Number of subjects: 12
Study: 7613823

Group type: EXPERIMENTAL
Intervention: Unilateral cryptorchid men
Number of subjects: 699

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Bilateral cryptorchid men
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Age at orchidopexy
Number of subjects: 699
Study: 2115680

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100-300 mg/day)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Maprotiline (100-300 mg/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Total Sleep Deprivation (TSD) before and after one week of antidepressant medication
Number of subjects: 42
Study: 6107585

Group type: EXPERIMENTAL
Intervention: Transfer factor (TF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 30735073

Group type: EXPERIMENTAL
Intervention: DHA (3 g/day)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: OO (3 g/day)
Number of subjects: 86

Group type: COMPARATOR
Intervention: EPA (3 g/day)
Number of subjects: 86
Study: 28316177

Group type: EXPERIMENTAL
Intervention: Tertiary hospital guided and community‐driven family self‐help cardiac rehabilitation for 3 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine secondary treatment for 3 months
Number of subjects: 80
Study: 25524534

Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy (TLH) using Electrosurgical Bipolar Vessel Sealing (EBVS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Vaginal Hysterectomy (VH) using Electrosurgical Bipolar Vessel Sealing (EBVS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Total Abdominal Hysterectomy (TAH) using Electrosurgical Bipolar Vessel Sealing (EBVS)
Number of subjects: 90
Study: 24039917

Group type: EXPERIMENTAL
Intervention: e-learning group with case-based teaching
Number of subjects: 63

Group type: COMPARATOR
Intervention: classroom teaching
Number of subjects: 63

Group type: COMPARATOR
Intervention: e-learning group with eBook teaching material
Number of subjects: 63
Study: 17218227

Group type: EXPERIMENTAL
Intervention: Endometrial rollerball ablation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Endometrial resection
Number of subjects: 48
Study: 15610889

Group type: EXPERIMENTAL
Intervention: Laparoscopic VIH repair
Number of subjects: 314

Group type: COMPARATOR
Intervention: Open VIH repair
Number of subjects: 314
Study: 10811678

Group type: COMPARATOR
Intervention: Ciprofloxacin 500 mg orally every 8 hours
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg orally every 8 hours plus Rifampin 300 mg orally every 12 hours
Number of subjects: 130
Study: 8594266

Group type: EXPERIMENTAL
Intervention: 50 mg/d of alpha tocopherol
Number of subjects: 22269

Group type: EXPERIMENTAL
Intervention: 20 mg/d of beta carotene
Number of subjects: 22269

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22269

Group type: EXPERIMENTAL
Intervention: Alpha tocopherol plus beta carotene
Number of subjects: 22269

Group type: EXPERIMENTAL
Intervention: Beta carotene
Number of subjects: 22269
Study: 1410953

Group type: EXPERIMENTAL
Intervention: Routine intervention by a general practitioner with follow-up at three-month intervals for one year
Number of subjects: 178

Group type: COMPARATOR
Intervention: Mini-intervention (control group) with follow-up only after 12 months
Number of subjects: 178
Study: 3891813

Group type: EXPERIMENTAL
Intervention: Methylphenidate 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Methylphenidate 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Methylphenidate 15 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Optimal dose levels of Methylphenidate
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fixed-dose and milligram-per-kilogram comparisons
Number of subjects: 12